GENENTECH RETRIEVING ACTIVASE, PROTROPIN AND GAMMA INTERFERON FROM R&D PARTNERSHIPS IN $400 MIL. STOCK TRANSACTION; FIRM DECLARES STOCK SPLIT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".